Literature DB >> 15052390

Heavy cannabis users seeking treatment- prevalence of psychiatric disorders.

Mikkel Arendt1, Povl Munk-Jørgensen.   

Abstract

AIMS: The aim of this study was to estimate the prevalence of psychiatric disorders among 1439 heavy cannabis users seeking treatment for abuse problems in Denmark.
DESIGN: Using two different registers, we compared cannabis users with 9122 abusers of other substances.
FINDINGS: (1). Cannabis users were younger and more often males, but otherwise demographic data suggested that the group was as marginalized as users of hard drugs. (2). Additional abuse of other substances was common. (3). Even though cannabis users were generally young, 27.5% had at some point been inpatients at psychiatric hospitals with disorders unrelated to psychoactive substance abuse. (4). Cannabis users had significantly raised levels of depression (p < 0.001) and personality disorders (p < 0.0001) compared with users of other drugs, while the prevalence of schizophrenia was marginally raised (p < 0.05). The results were obtained after adjustment for age, gender and secondary abuse. Analyses were made using logistic regression methods.
CONCLUSION: Co-morbid psychiatric disorders are common among heavy cannabis users seeking treatment. Some psychiatric disorders occur more frequently in this group compared with users of other substances.

Entities:  

Mesh:

Year:  2004        PMID: 15052390     DOI: 10.1007/s00127-004-0719-7

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  11 in total

1.  Repeated cannabinoid administration increases indices of noradrenergic activity in rats.

Authors:  M E Page; V C Oropeza; S E Sparks; Y Qian; A S Menko; E J Van Bockstaele
Journal:  Pharmacol Biochem Behav       Date:  2007-01-09       Impact factor: 3.533

2.  Exploring the mediational role of coping motives for marijuana use in terms of the relation between anxiety sensitivity and marijuana dependence.

Authors:  Kirsten Johnson; Jennifer L Mullin; Erin C Marshall; Marcel O Bonn-Miller; Michael Zvolensky
Journal:  Am J Addict       Date:  2010 May-Jun

3.  Cortical adrenoceptor expression, function and adaptation under conditions of cannabinoid receptor deletion.

Authors:  B A S Reyes; A F Carvalho; P Szot; D J Kalamarides; Q Wang; L G Kirby; E J Van Bockstaele
Journal:  Exp Neurol       Date:  2017-03-21       Impact factor: 5.330

4.  Uni-morbid and co-occurring marijuana and tobacco use: examination of concurrent associations with negative mood states.

Authors:  Marcel O Bonn-Miller; Michael J Zvolensky; Kirsten A Johnson
Journal:  J Addict Dis       Date:  2010-01

5.  A comparison of psychosocial and cognitive functioning between depressed and non-depressed patients with cannabis dependence.

Authors:  Alex M Secora; David Eddie; Bertram J Wyman; Daniel J Brooks; John J Mariani; Frances R Levin
Journal:  J Addict Dis       Date:  2010-07

6.  First-episode drug-induced psychosis: a medium term follow up study reveals a high-risk group.

Authors:  Kathleen Crebbin; Emma Mitford; Roger Paxton; Douglas Turkington
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-01-27       Impact factor: 4.328

7.  A retrospective analysis of cannabis use in a cohort of mentally ill patients in Sri Lanka and its implications on policy development.

Authors:  Chaturaka Rodrigo; Srina Welgama; Alwis Gunawardana; Chinthaka Maithripala; Gamini Jayananda; Senaka Rajapakse
Journal:  Subst Abuse Treat Prev Policy       Date:  2010-07-08

8.  Effects of research setting on observed depressive symptoms in marijuana users.

Authors:  John J Mariani; Margaret Haney; Carl L Hart; Suzanne K Vosburg; Frances R Levin
Journal:  J Subst Abuse Treat       Date:  2009-06-21

9.  Cannabis and psychopathology : update 2004.

Authors:  Sandeep Grover; Debasish Basu
Journal:  Indian J Psychiatry       Date:  2004-10       Impact factor: 1.759

10.  Cannabis and schizophrenia spectrum disorders: a review of clinical studies.

Authors:  Chaturaka Rodrigo; Senaka Rajapakse
Journal:  Indian J Psychol Med       Date:  2009-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.